BACKGROUND: Infiltration of inflammatory cells into the colon plays an important role in the onset and course of inflammatory bowel disease. G-protein-coupled receptor kinase 6 (GRK6) is an intracellular kinase that regulates the sensitivity of certain G-protein-coupled receptors, including those involved in the migration of inflammatory cells. Therefore, it is hypothesised that GRK6 plays a role in determining the course of inflammation. AIM: To analyse the role of GRK6 in the course of dextran sodium sulphate (DSS)-induced colitis. METHODS: Colitis was induced by administering 1% DSS in drinking water to GRK6(-/-), GRK6(+/-) and wild-type (WT) mice for 6 days. The severity of colitis was assessed on the basis of clinical signs, colon length and histology. Moreover, keratinocyte-derived chemokine (KC) levels, granulocyte infiltration, interleukin 1beta (IL1beta), CD4, CD8 and forkhead box protein P3 (FoxP3) expression in the colon were determined. In addition, regulatory T cell function in WT and GRK6(-/-) mice was analysed. The chemotactic response of granulocytes to colon culture supernatants was assessed using a transendothelial migration assay. RESULTS: The severity of colitis was increased in GRK6(-/-) and GRK6(+/-) mice and was accompanied by increased KC levels and increased granulocyte infiltration. Moreover, the chemotactic response of GRK6(-/-) granulocytes to supernatants of colon cultures was enhanced. Interestingly, the WT mice completely recovered from colitis, whereas the GRK6(-/-) and GRK6(+/-) mice developed chronic colitis, which was accompanied by increased IL1beta and CD4 expression and decreased FoxP3 expression. Moreover, regulatory T cell function was impaired in the GRK6(-/-) mice. CONCLUSIONS: The intracellular level of GRK6 is an important factor in determining the onset, severity and chronicity of DSS-induced colitis.
BACKGROUND: Infiltration of inflammatory cells into the colon plays an important role in the onset and course of inflammatory bowel disease. G-protein-coupled receptor kinase 6 (GRK6) is an intracellular kinase that regulates the sensitivity of certain G-protein-coupled receptors, including those involved in the migration of inflammatory cells. Therefore, it is hypothesised that GRK6 plays a role in determining the course of inflammation. AIM: To analyse the role of GRK6 in the course of dextran sodium sulphate (DSS)-induced colitis. METHODS:Colitis was induced by administering 1% DSS in drinking water to GRK6(-/-), GRK6(+/-) and wild-type (WT) mice for 6 days. The severity of colitis was assessed on the basis of clinical signs, colon length and histology. Moreover, keratinocyte-derived chemokine (KC) levels, granulocyte infiltration, interleukin 1beta (IL1beta), CD4, CD8 and forkhead box protein P3 (FoxP3) expression in the colon were determined. In addition, regulatory T cell function in WT and GRK6(-/-) mice was analysed. The chemotactic response of granulocytes to colon culture supernatants was assessed using a transendothelial migration assay. RESULTS: The severity of colitis was increased in GRK6(-/-) and GRK6(+/-) mice and was accompanied by increased KC levels and increased granulocyte infiltration. Moreover, the chemotactic response of GRK6(-/-) granulocytes to supernatants of colon cultures was enhanced. Interestingly, the WT mice completely recovered from colitis, whereas the GRK6(-/-) and GRK6(+/-) mice developed chronic colitis, which was accompanied by increased IL1beta and CD4 expression and decreased FoxP3 expression. Moreover, regulatory T cell function was impaired in the GRK6(-/-) mice. CONCLUSIONS: The intracellular level of GRK6 is an important factor in determining the onset, severity and chronicity of DSS-induced colitis.
Authors: Alan M Fong; Richard T Premont; Ricardo M Richardson; Yen-Rei A Yu; Robert J Lefkowitz; Dhavalkumar D Patel Journal: Proc Natl Acad Sci U S A Date: 2002-05-28 Impact factor: 11.205
Authors: A Imada; K Ina; M Shimada; T Yokoyama; Y Yokoyama; Y Nishio; T Yamaguchi; T Ando; K Kusugami Journal: Scand J Gastroenterol Date: 2001-08 Impact factor: 2.423
Authors: P G Andres; P L Beck; E Mizoguchi; A Mizoguchi; A K Bhan; T Dawson; W A Kuziel; N Maeda; R P MacDermott; D K Podolsky; H C Reinecker Journal: J Immunol Date: 2000-06-15 Impact factor: 5.422
Authors: Annemieke Kavelaars; Anne Vroon; Roel P Raatgever; Alan M Fong; Richard T Premont; Dhavalkumar D Patel; Robert J Lefkowitz; Cobi J Heijnen Journal: J Immunol Date: 2003-12-01 Impact factor: 5.422
Authors: Michael D Steury; Ho Jun Kang; Taehyung Lee; Peter C Lucas; Laura R McCabe; Narayanan Parameswaran Journal: Physiol Genomics Date: 2018-03-23 Impact factor: 3.107
Authors: Niels Eijkelkamp; Cobi J Heijnen; Hanneke L D M Willemen; Ronald Deumens; Elbert A J Joosten; Wendy Kleibeuker; Ilona J M den Hartog; Cindy T J van Velthoven; Cora Nijboer; Mohammed A Nassar; Gerald W Dorn; John N Wood; Annemieke Kavelaars Journal: J Neurosci Date: 2010-02-10 Impact factor: 6.167
Authors: Teresa K Tarrant; Rishi R Rampersad; Denise Esserman; Lisa R Rothlein; Peng Liu; Richard T Premont; Robert J Lefkowitz; David M Lee; Dhavalkumar D Patel Journal: Clin Immunol Date: 2008-07-26 Impact factor: 3.969